e-learning
resources
Stockholm 2007
Monday 17.09.2007
Airway regulation, provocation and monitoring I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Airway inflammation markers in COPD
O. Plekhanova (Dniepropetrovsk, Ukraine)
Source:
Annual Congress 2007 - Airway regulation, provocation and monitoring I
Session:
Airway regulation, provocation and monitoring I
Session type:
Thematic Poster Session
Number:
2180
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Plekhanova (Dniepropetrovsk, Ukraine). Airway inflammation markers in COPD. Eur Respir J 2007; 30: Suppl. 51, 2180
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Induced sputum and airway inflammation in asthma and COPD
Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment
Year: 2006
Bronchial reversibility and airway inflammation in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003
ADAM33
SNPs are associated with airway hyperresponsiveness and airway inflammation in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 3s
Year: 2005
Galectn-3 : marker of airway inflammation in bronchial asthma
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Inflammatory cells and airway remodelling in COPD
Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
Year: 2019
Airway inflammation and airway pathophysiology in older asthmatics
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Airway inflammation and airway dynamics during deep inspiration in asthma and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 831s
Year: 2006
The EvA-Study: Markers of emphysema versus airway disease in COPD
Source: Annual Congress 2009 - EU Research Programmes: 1.GABRIEL 2.EvA 3.COPACETIC
Year: 2009
Airway remodelling in asthma is related to particular characteristics of airway inflammation
Source: Eur Respir J 2002; 20: Suppl. 38, 188s
Year: 2002
Chronic sputum production in COPD is a marker for airway inflammation and colonisation
Source: Eur Respir J 2004; 24: Suppl. 48, 306s
Year: 2004
Relationship between peripheral airway obstruction and airway inflammation in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 509s
Year: 2006
Autoimmunity in airway inflammation and asthma
Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease
Year: 2017
Markers of inflammation and airway responses to allergen in asthmatic patients
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008
Induced sputum and bronchial hyperresponsiveness in COPD patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Airway inflammatory mediators and airway wall remodelling in asthma
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009
The association between airway hyperresponsiveness to mannitol and T2 inflammatory markers in asthma versus COPD
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003
Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept